Innovative Designer Peptides to Treat Cardiovascular, Metabolic & Kidney Disease
OUR SCIENCE
MANP, our innovative GC-A receptor activator, pioneers hypertension research
OUR TEAM
Our greatest health science breakthroughs occurred because someone was bold enough to challenge the status quo
Our Clinical Studies
The BOLD-HTN Study advances our understanding of MANP as a novel GC-A activating designer peptide for uncontrolled blood pressure. This Phase 2 clinical trial lays the foundation for its development as an innovative medicine for hypertension.
Check out our news and publications
Pharmaceutical Development
At E-Star, our focus is clear: advancing the development of innovative therapies for hypertension. We are deeply committed to supporting every stage of the journey, from preclinical strategy to hands-on clinical execution. By offering a full range of product development services, we help our clients move efficiently from concept to market, ensuring that promising therapies reach the patients who need them most.
Our consultants bring extensive industry knowledge and first-hand experience in hypertension drug development. This allows us to anticipate challenges, streamline processes, and guide our clients through the complex and rapidly changing regulatory and clinical landscape. With E-Star, you gain a dedicated partner committed to helping you navigate the evolving world of hypertension treatment and deliver meaningful outcomes.